Health experts have issued a stark warning over the growing threat of antibiotic resistance, as discussions take place at a major infectious diseases conference in Venice from March 26 to 28, 2026.
The event brings together leading specialists to address critical global health challenges, including drug-resistant bacteria, sepsis, and emerging fungal infections, with a focus on accelerating life-saving medical innovations.
According to the Global Burden of Disease Study, antibiotic-resistant infections were linked to about 4.71 million deaths worldwide, including 1.14 million directly caused by resistance. Without effective intervention, annual deaths could reach 2 million by 2050, with cumulative fatalities exceeding 39 million.
In Europe alone, resistant bacterial infections cause more than 35,000 deaths each year, highlighting the urgent need for improved treatments and prevention strategies.
Conference discussions are focusing on key areas such as superbugs, sepsis management, and resistant fungal infections like Candida auris.
Experts are also exploring future solutions, including artificial intelligence for faster diagnosis, bacteriophage therapy, and the development of targeted vaccines.
Researchers warn that mortality rates in severe cases can exceed 40% for some highly resistant infections, emphasizing that antibiotic resistance is now an immediate global health priority requiring coordinated international action.




